DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/p6n98f/countryfocus) has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia" report to their offering.
Healthcare, Regulatory and Reimbursement Landscape - Indonesia. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Indonesia, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by Our team of industry experts.
In 2013, Indonesia's population stood at 251 million, up from 238 million in 2008. The major factors that contributed to the growth in the population are an increase in net migration and a drop in the death rate. The country's pharmaceutical market was estimated to have been worth $5 billion in 2013 and is expected to reach $9.9 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 10.2%. In 2010, according to US Commercial Service estimates, the country's medical device market was worth $573m.
The positive trends in the Indonesian healthcare market can primarily be attributed to:
Key Topics Covered:
1 Tables & Figures
3 Overview of Pharmaceutical and Medical Device Markets
4 Market Access
5 Country Analysis
6 Opportunities and Challenges
For more information visit http://www.researchandmarkets.com/research/p6n98f/countryfocus
Source: Research and Markets